|
Originally published In Press as doi:10.1074/jbc.M412817200 on December 21, 2004
Originally published In Press as doi:10.1074/jbc.M412817200 on December 15, 2004
Originally published In Press as doi:10.1074/jbc.M412817200 on December 8, 2004
Originally published In Press as doi:10.1074/jbc.M412817200 on December 6, 2004
J. Biol. Chem., Vol. 280, Issue 8, 7317-7325, February 25, 2005
Bisphosphonates and Estrogens Inhibit Osteocyte Apoptosis via Distinct Molecular Mechanisms Downstream of Extracellular Signal-regulated Kinase Activation*
Lilian I. Plotkin,
J. Ignacio Aguirre,
Stavroula Kousteni,
Stavros C. Manolagas, and
Teresita Bellido
From the
Division of Endocrinology and Metabolism, the Center for Osteoporosis and Metabolic Bone Diseases, the Central Arkansas Veterans Affairs Healthcare System, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205-7199
Both estrogens and bisphosphonates attenuate osteocyte apoptosis by activating the extracellular signal-regulated kinases (ERKs). However, whereas estrogens activate ERKs via an extranuclear function of the estrogen receptor, bisphosphonates do so by opening connexin 43 hemichannels. Here, we demonstrated that the signaling events downstream of ERKs induced by these two stimuli are also distinct. Inhibition of osteocyte apoptosis by estrogens requires nuclear accumulation of ERKs and activation of downstream transcription factors. On the other hand, anti-apoptosis induced by bisphosphonates requires neither transcription nor ERK-dependent transcription factors. Instead, the effect of bisphosphonates is abolished when ERKs are restricted to the nucleus by blocking CRM1/exportin1-mediated nuclear protein export or by expressing nuclear-anchored ERKs, but it is unaffected in cells expressing cytoplasmic-anchored ERKs. Connexin 43/ERK-mediated anti-apoptosis induced by bisphosphonates requires the kinase activity of the cytoplasmic target of ERKs, p90RSK, which in turn phosphorylates the pro-apoptotic protein BAD and C/EBP . Phosphorylation of BAD renders it inactive, whereas phosphorylation of C/EBP leads to binding of pro-caspases, thus inhibiting apoptosis independently of the transcriptional activity of this transcription factor. Consistent with the evidence that estrogens and bisphosphonates phosphorylate diverse targets of ERKs, probably resulting from activation of spatially distinct pools of these kinases, the two agents had additive effects on osteocyte survival.
Received for publication, November 12, 2004
* This research was supported by National Institutes of Health Grants KO2-AR02127 (to T. B.) and P01-AG13918 (to S. C. M.) and by the Department of Veterans Affairs Merit and Research Enhancement Award Program awards (to S. C. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 501-686-8971; Fax: 501-686-8148; E-mail: tmbellido{at}uams.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
F. Lima, C. Niger, C. Hebert, and J. P. Stains
Connexin43 Potentiates Osteoblast Responsiveness to Fibroblast Growth Factor 2 via a Protein Kinase C-Delta/Runx2-dependent Mechanism
Mol. Biol. Cell,
June 1, 2009;
20(11):
2697 - 2708.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. D. Pajevic
Regulation of Bone Resorption and Mineral Homeostasis by Osteocytes
IBMS BoneKEy,
February 1, 2009;
6(2):
63 - 70.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Clarke
Normal Bone Anatomy and Physiology
Clin. J. Am. Soc. Nephrol.,
November 1, 2008;
3(Supplement_3):
S131 - S139.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. P. Coxon
An Update on the Pharmacology of Bisphosphonates and Analogues with Lower Bone Affinity
IBMS BoneKEy,
October 1, 2008;
5(10):
357 - 369.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. T. Drake, B. L. Clarke, and S. Khosla
Bisphosphonates: Mechanism of Action and Role in Clinical Practice
Mayo Clin. Proc.,
September 1, 2008;
83(9):
1032 - 1045.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Vasconsuelo, L. Milanesi, and R. Boland
17{beta}-Estradiol abrogates apoptosis in murine skeletal muscle cells through estrogen receptors: role of the phosphatidylinositol 3-kinase/Akt pathway
J. Endocrinol.,
February 1, 2008;
196(2):
385 - 397.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R. Hammes and E. R. Levin
Extranuclear Steroid Receptors: Nature and Actions
Endocr. Rev.,
December 1, 2007;
28(7):
726 - 741.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Horsch, H. de Wet, M. M. Schuurmans, F. Allie-Reid, A. C. B. Cato, J. Cunningham, J. M. Burrin, F. S. Hough, and P. A. Hulley
Mitogen-Activated Protein Kinase Phosphatase 1/Dual Specificity Phosphatase 1 Mediates Glucocorticoid Inhibition of Osteoblast Proliferation
Mol. Endocrinol.,
December 1, 2007;
21(12):
2929 - 2940.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. I. Aguirre, L. I. Plotkin, A. R. Gortazar, M. M. Millan, C. A. O'Brien, S. C. Manolagas, and T. Bellido
A Novel Ligand-independent Function of the Estrogen Receptor Is Essential for Osteocyte and Osteoblast Mechanotransduction
J. Biol. Chem.,
August 31, 2007;
282(35):
25501 - 25508.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Huang, M. Khoe, M. Befekadu, S. Chung, Y. Takata, D. Ilic, and M. Bryer-Ash
Focal adhesion kinase mediates cell survival via NF-{kappa}B and ERK signaling pathways
Am J Physiol Cell Physiol,
April 1, 2007;
292(4):
C1339 - C1352.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. G. G. Russell
Bisphosphonates: Mode of Action and Pharmacology
Pediatrics,
March 1, 2007;
119(Supplement_2):
S150 - S162.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. McClung
Bisphosphonate Therapy: To Stop or Not to Stop?
IBMS BoneKEy,
February 1, 2007;
4(2):
78 - 82.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Chung, C. H. M. Castro, M. Watkins, J. P. Stains, M. Y. Chung, V. L. Szejnfeld, K. Willecke, M. Theis, and R. Civitelli
Low peak bone mass and attenuated anabolic response to parathyroid hormone in mice with an osteoblast-specific deletion of connexin43
J. Cell Sci.,
October 15, 2006;
119(20):
4187 - 4198.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Rodriguez-Sinovas, K. Boengler, A. Cabestrero, P. Gres, M. Morente, M. Ruiz-Meana, I. Konietzka, E. Miro, A. Totzeck, G. Heusch, et al.
Translocation of Connexin 43 to the Inner Mitochondrial Membrane of Cardiomyocytes Through the Heat Shock Protein 90-Dependent TOM Pathway and Its Importance for Cardioprotection
Circ. Res.,
July 7, 2006;
99(1):
93 - 101.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Carrington and F. L. Bellino
Developing a Research Agenda in Biogerontology: Physiological Systems
Sci. Aging Knowl. Environ.,
June 28, 2006;
2006(10):
pe17 - pe17.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Almeida, L. Han, T. Bellido, S. C. Manolagas, and S. Kousteni
Wnt Proteins Prevent Apoptosis of Both Uncommitted Osteoblast Progenitors and Differentiated Osteoblasts by {beta}-Catenin-dependent and -independent Signaling Cascades Involving Src/ERK and Phosphatidylinositol 3-Kinase/AKT
J. Biol. Chem.,
December 16, 2005;
280(50):
41342 - 41351.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. I. Plotkin, I. Mathov, J. I. Aguirre, A. M. Parfitt, S. C. Manolagas, and T. Bellido
Mechanical stimulation prevents osteocyte apoptosis: requirement of integrins, Src kinases, and ERKs
Am J Physiol Cell Physiol,
September 1, 2005;
289(3):
C633 - C643.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. R. Levin
Integration of the Extranuclear and Nuclear Actions of Estrogen
Mol. Endocrinol.,
August 1, 2005;
19(8):
1951 - 1959.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Seeman and G. J. Strewler
Clinical and Basic Research Papers - February 2005 Selections
IBMS BoneKEy,
March 1, 2005;
2(3):
1 - 5.
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|